Established in July
Committee members
Review methods
Overview of the Ethics Committee
The Ethics Committee of Hebei Yiling Hospital was established in July 2013. It currently has 13 members, who are experts in medicine, bioethics and law as well as non-affiliated members of the public. There are also two secretaries.
The Ethics Committee office is on the 4th floor of the hospital's outpatient building, with a data room and related facilities for its work. The committee has drawn up its charter, working rules and procedures, and has filed them with the Medical Research Registration and Filing Information System and the Drug and Medical Device Clinical Trial Institution Filing Management Information System.
Purpose
By reviewing the scientific rigor and ethical soundness of clinical research projects, the committee ensures the protection of the dignity, safety and rights of research participants, promotes high scientific and ethical standards in biomedical research, and strengthens public trust in and support for clinical research.
Working basis
- Measures for the Ethical Review of Life Science and Medical Research Involving Human Subjects (2023), issued by the National Health Commission, the Ministry of Education, the Ministry of Science and Technology and the State Administration of Traditional Chinese Medicine
- Good Clinical Practice for Drug Clinical Trials (2020), issued by the National Medical Products Administration and the National Health Commission
- Good Clinical Practice for Medical Devices (2022), issued by the State Food and Drug Administration
- Interim Regulations on the Clinical Application Management of Human Organ Transplantation Technology, issued by the Ministry of Health
- The World Medical Association's Declaration of Helsinki
- The International Ethical Guidelines for Human Biomedical Research issued by the Council for International Organizations of Medical Sciences
Duties
The committee carries out independent, competent and timely review of the scientific and ethical soundness of biomedical research projects involving human subjects. The scope of review includes drug clinical trial projects, and review categories include initial review, follow-up review and re-review. The Ethics Committee Office manages the committee's day-to-day administrative affairs.
Review methods
The committee uses three review methods: meeting review, emergency meeting review and expedited review. A lead-reviewer system applies: each project has a designated lead reviewer who completes a review worksheet.
Meeting review is the main method, and members should pre-review submitted projects before the meeting. If significant or serious problems arise during research that endanger participant safety, an emergency meeting review is convened. Expedited review supplements meeting review to improve efficiency. It mainly applies to minor amendments to a protocol that do not affect the trial's risk-benefit ratio, to annual or periodic follow-up review of projects that have not yet enrolled participants, and to review of expected serious adverse events.
Contact information
Medical Ethics Committee
- Overview of the Ethics Committee
- List of Ethics Committee members
- Charter of the Medical Ethics Committee
- Application forms and materials download
Questions about ethics review?
Contact the Ethics Committee Office, 4th floor, Outpatient Building, Hebei Yiling Hospital.